USFDA successfully completes inspection at Indoco's API Kilo Lab manufacturing facility and IAS division with zero observations

News Coverages - USFDA successfully completes inspection at Indoco's API Kilo Lab manufacturing facility and IAS division with zero observations

US FDA concludes audit of Indoco's Rabale facility & IAS division with zero observations, business-standard.com
- May 17, 2024
USFDA concludes inspection of Indoco’s Rabale facility, expresspharma.in
- May 16, 2024
US FDA successfully completes inspection at Indoco’s API Kilo Lab manufacturing facility and IAS division without any observations, pharmabiz.com
- May 16, 2024
USFDA inspection: With zero observation at Indoco Remedies, thehealthmaster.com
- May 16, 2024
USFDA inspection: With zero observation at Indoco Remedies x.com/CNBCTV18Live
- May 16, 2024
USFDA completes inspection with zero observation at API Kilo Lab x.com/ETNOW
- May 16, 2024